We are live on ! Find out more
PCM

Pentwater Capital Management Portfolio holdings

AUM $19.3B
1-Year Est. Return 58.13%
This Fund
S&P 500
This Quarter Est. Return
+14.05%
1 Year Est. Return
+58.13%
3 Year Est. Return
+179.76%
5 Year Est. Return
+629.27%
10 Year Est. Return
+5,046.05%
AUM
$12.1B
AUM Growth
+$1.64B
Cap. Flow
+$978M
Cap. Flow %
8.07%
Top 10 Hldgs %
60.36%
Holding
446
New
110
Increased
68
Reduced
64
Closed
143

Top Buys

Rank Stock Value
1
NUAN
Nuance Communications, Inc.
NUAN
+$644M
2
PPD
PPD, Inc. Common Stock
PPD
+$547M
3
KSU
Kansas City Southern
KSU
+$446M
4
PFPT
Proofpoint, Inc.
PFPT
+$409M
5
INFO
IHS Markit Ltd. Common Shares
INFO
+$220M

Top Sells

Rank Stock Value
1
XLNX
Xilinx Inc
XLNX
+$481M
2
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$456M
3
IPHI
INPHI CORPORATION
IPHI
+$365M
4
CLGX
Corelogic, Inc.
CLGX
+$311M
5
VAR
Varian Medical Systems, Inc.
VAR
+$268M

Sector Composition

Rank Sector Weight
1 Technology 19.76%
2 Healthcare 16.44%
3 Communication Services 8.82%
4 Industrials 6.64%
5 Consumer Discretionary 4.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FPRX
426
DELISTED
Five Prime Therapeutics, Inc.
FPRX
– –
-1,000,200
Closed -$37.7M
VAR
427
DELISTED
Varian Medical Systems, Inc.
VAR
– –
-1,515,863
Closed -$268M
MIK
428
DELISTED
Michaels Stores, Inc
MIK
– –
-800,100
Closed -$17.6M
MSACU
429
DELISTED
Medicus Sciences Acquisition Corp. Unit
MSACU
– –
-50,000
Closed -$493K
PS
430
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
– –
-450,100
Closed -$10.1M
PAND
431
DELISTED
Pandion Therapeutics Inc. Common Stock
PAND
– –
-150,000
Closed -$9.01M
HMSY
432
DELISTED
HMS Holdings Corp.
HMSY
– –
-419,000
Closed -$15.5M
TRQ
433
CALL
DELISTED
Turquoise Hill Resources Ltd
TRQ
– –
-100,000
Closed -$1.61M
TCF
434
DELISTED
TCF Financial Corporation Common Stock
TCF
– –
-1,821,000
Closed -$84.6M
CBPO
435
DELISTED
China Biologic Products Holdings, Inc.
CBPO
– –
-1,184,021
Closed -$140M
QDROU
436
DELISTED
Quadro Acquisition One Corp. Unit
QDROU
– –
-100,000
Closed -$994K
HSKA
437
DELISTED
Heska Corp
HSKA
– –
-4,326
Closed -$729K
PTOCU
438
DELISTED
Pine TechnologYES Acquisition Corp. Unit
PTOCU
– –
-475,000
Closed -$4.72M
OZON
439
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
– –
-5,000
Closed -$280K
CKH
440
DELISTED
Seacor Holdings Inc.
CKH
– –
-172,578
Closed -$7.03M
CADE
441
DELISTED
Cadence Bancorporation
CADE
– –
-325,000
Closed -$6.74M
INTZ
442
DELISTED
INTRUSION INC NEW
INTZ
– –
-25,000
Closed -$584K
14 15 16 17
18

Similar funds

CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
NAM
Nissay Asset Management Tokyo, Japan $18.9B AUM 27.21% 1-Year Est. Return

Pentwater Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Pentwater Capital Management held 446 positions worth $12.1B, up 16% from $10.5B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Pentwater Capital Management deployed $978M of net new capital in Q2 2021, opening 110 new positions and adding to 68 existing holdings. Its largest new stake was Nuance Communications, Inc.: 12,230,000 shares worth $666M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Xilinx Inc, an estimated $481M trimmed.

  • Pentwater Capital Management's largest Q2 2021 buy was Nuance Communications, Inc.: 12,230,000 shares worth $666M.
  • Pentwater Capital Management added most to PPD, Inc. Common Stock in Q2 2021, an estimated $547M increase.
  • Pentwater Capital Management's biggest Q2 2021 reduction was Xilinx Inc, cutting an estimated $481M.
  • Pentwater Capital Management fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $456M.
  • Pentwater Capital Management's ten largest holdings make up 60% of its $12.1B portfolio in Q2 2021.
  • Pentwater Capital Management opened 110 new positions and closed 143 in Q2 2021.
  • Pentwater Capital Management's portfolio value rose 16% quarter-over-quarter to $12.1B.

Based on Pentwater Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.